Enabling individualized therapy through nanotechnology - Test2 - elhamkhani - TriplyDB

Enabling individualized therapy through nanotechnology

Enabling individualized therapy through nanotechnology

http://www.wikidata.org/entity/Q33917755

about

Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy Epigenetics advancing personalized nanomedicine in cancer therapy Nanotechnology in cancer therapy Nanomedicine: promises and challenges for the future of public health Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine Nanotechnology-Based Drug Delivery Systems for Melanoma Antitumoral Therapy: A Review Theranostic applications: Non-ionizing cellular and molecular imaging through innovative nanosystems for early diagnosis and therapy.Reconstructing the pipeline by introducing multiplexed multiple reaction monitoring mass spectrometry for cancer biomarker verification: an NCI-CPTC initiative perspective.Cefazolin-loaded mesoporous silicon microparticles show sustained bactericidal effect against Staphylococcus aureus.Multi-stage delivery nano-particle systems for therapeutic applications Graphene as a photothermal switch for controlled drug release.Nanotechnology in medicine: from inception to market domination Reservoir-based drug delivery systems utilizing microtechnology.Silicon micro- and nanofabrication for medicine Multifunctional to multistage delivery systems: The evolution of nanoparticles for biomedical applications RNA interference in the clinic: challenges and future directions.Nanomaterials for regenerative medicine.Nanomedicine: application areas and development prospects.Liposomal systems as drug delivery vehicles for dermal and transdermal applications.Oral drug delivery systems comprising altered geometric configurations for controlled drug delivery.Potential role of metabolomic approaches for Chinese medicine syndromes and herbal medicine.Emerging role of radiolabeled nanoparticles as an effective diagnostic technique.Systems biology technologies enable personalized traditional Chinese medicine: a systematic review.Implantable microchip: the futuristic controlled drug delivery system.Ceramic nanoparticles: Recompense, cellular uptake and toxicity concerns.Pioneering medical advances through nanofluidic implantable technologies.A novel strategy combining magnetic particle hyperthermia pulses with enhanced performance binary ferrite carriers for effective in vitro manipulation of primary human osteogenic sarcoma cells.The Emerging Role of Nanotechnology in Cell and Organ Transplantation.NCI investment in nanotechnology: achievements and challenges for the future.Rapid Biosynthesis of Silver Nanoparticles Using Pepino (Solanum muricatum) Leaf Extract and Their Cytotoxicity on HeLa Cells.Anti-cancer studies of noble metal nanoparticles synthesized using different plant extracts Cardiovascular nanomedicine: a posse ad esse.Smart microneedle coatings for controlled delivery and biomedical analysis.Understanding the Pathological Basis of Neurological Diseases Through Diagnostic Platforms Based on Innovations in Biomedical Engineering: New Concepts and Theranostics Perspectives.Structural identification of the novel 3 way-junction motif Microfluidic Platforms for Evaluation of Nanobiomaterials: A Review

P2860

Q26745710-A317D0DC-DF07-4355-9807-F4B3A05B9855 Q27010637-7BB35CF2-645E-4433-A2E1-19D23C34BBAF Q27023013-1FC2380F-8338-40FF-9383-074AA2443D5C Q28384103-C3166A65-0D9B-4748-8073-C4423A149709 Q28391849-21EBC45A-0C02-42BA-AD25-3E15FD7D0B5C Q28394719-B9E68CB4-7B39-4340-9EC6-EA70A996D1DA Q30471593-DC516F85-0807-4011-A902-9DF251BAB0DD Q33669587-898337F3-D560-4314-AC2E-3876E2BAE913 Q33716086-B9660BDD-F506-4290-8FAF-B0FDF43D76F0 Q34166491-04423E32-45ED-4E29-A866-11A7F3E3F42C Q35182431-1D61C14F-AE45-4EB4-8E5B-D163231DE9A8 Q35852640-5794989E-7E8B-4A37-AC99-25F6DBC1FD18 Q36198990-75E84B9D-7C29-48D1-BF5D-103B2EB5F3E8 Q37184228-07F3B42C-5ABF-48CC-B020-C20407BAA067 Q37609544-70937319-5241-4F50-AD9A-13874556E7EF Q37821230-203B840B-B951-441F-BB56-0DF26D12FD60 Q37823603-B1B3B8E8-C7A5-4092-B23C-158CE678EF6F Q37891690-B844CC64-3649-435E-B9CB-E4D5ED24665A Q37909120-2C2B8F9B-3A69-4009-9694-C7A2A34941F0 Q37982049-0AA8113B-AB2F-4E66-8BC0-5C5D624C57CC Q37994122-343B931F-24E0-44FF-B14A-706F0CAA517A Q38027231-7329B6BB-0EA3-4580-B197-5343121E1D9D Q38066235-2B346A1D-C062-471C-AF1B-C00AC57C685B Q38206542-232AF29F-430F-40A1-AEEE-DCB6C6A1765F Q38250374-B5A2C9FA-9566-48D0-BBD8-3001B5EBD716 Q38745290-92E67404-91E3-462B-AEF7-A4F8535DFF56 Q38756646-63E926B8-F7F1-4C7D-A2DD-4727909D7844 Q38852662-66F6F5AA-35AB-43E2-9310-7D72DE98E75E Q39093463-9DE981A3-2794-4159-8F52-D4F782865774 Q40967964-F0F6B06F-47D9-409B-A3D1-B3FBEDF26EC3 Q41520311-3BCC8C5E-4A4C-4833-B013-8208DF0C9BEC Q43232585-AD026891-E4DB-4944-938B-7BFE39378B7A Q51514678-B510B631-114E-4F63-9192-7C0B594674EF Q52679172-9DAFA5B6-F679-483E-977D-67BC03596C55 Q57271409-6FA12835-8156-44A1-8C65-4AABF5692919 Q58910627-AB61EC03-8EF7-4DB5-81C3-1258085D58F0

P2860

Enabling individualized therapy through nanotechnology

http://www.wikidata.org/entity/Q33917755

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Enabling individualized therapy through nanotechnology

@ast

Enabling individualized therapy through nanotechnology

@en

type

label

Enabling individualized therapy through nanotechnology

@ast

Enabling individualized therapy through nanotechnology

@en

prefLabel

Enabling individualized therapy through nanotechnology

@ast

Enabling individualized therapy through nanotechnology

@en

P1433

Q33917755-99881BF6-F3A0-41A7-B2B3-1B98D0E65E1B

P1476

Q33917755-79966BDA-E3BA-46ED-8B29-12F962D3E611

P2093

Q33917755-19C88DD8-9AB5-4029-B9FE-847A0FFB900E

Q33917755-2ADB1870-1EA8-4F49-841E-F380DDAB98D8

Q33917755-2C0C4AF5-A98E-4E73-9B2D-548424856C28

Q33917755-48943150-69A7-4B55-8360-EFAA8D58A7F9

Q33917755-49BAEF42-8CCC-464D-AEB8-A9CD24372DE8

Q33917755-4F7C1962-1D3F-4E98-AC7A-EE7DFD619684

Q33917755-5923E9C9-DD0D-4342-BB84-7228D3AC985E

Q33917755-5B9FE1E3-3774-4AF1-8BAA-C750BAB29224

Q33917755-5C96B6A9-9AC0-48F4-AD61-E71DA03BFC27

Q33917755-7B86C432-78C7-40D5-B8C5-1B5B299511F6

P2860

Q33917755-009B25F9-67B6-43C2-9EA4-99A5FA88FE3C

Q33917755-01720344-82B4-4A0C-AC51-C564B5D7E9B9

Q33917755-0310EAB4-1AC4-4B09-9DAC-AEDF49E88E75

Q33917755-031C60D3-7D5C-4B13-B91C-C465949DCA41

Q33917755-03703B1E-1193-4D20-8D2D-2C79B21B52FB

Q33917755-03DC38DB-676A-47B1-B273-AD4A15B1846D

Q33917755-049AB875-E42E-4AE4-8BEB-3CED83DF77EE

Q33917755-05548DF6-7A7F-42EA-A8C1-BF65013FBC13

Q33917755-08318848-382A-4455-B56B-4A93D2988A39

Q33917755-08959A0C-13C0-4C34-A07F-775898CBAA6D

P304

Q33917755-3018847D-139E-4A33-88D5-B11417657D88

P31

Q33917755-1B4F336B-7626-4A0F-B476-A60C325FB9FF

P356

Q33917755-17044964-2038-44CC-BFA1-95C6F64F2C42

P433

Q33917755-4FBEDE1A-6034-4974-9715-A949FC0C2843

P478

Q33917755-C52364EB-8A3C-4B1C-853B-E30D897874FB

P50

Q33917755-18B05C06-5CCE-4FAF-AEF4-1326B8EC0D19

Q33917755-4851770C-C4DA-43F9-B51C-E160852B8B1D

Q33917755-7B5D781C-EBBB-4D0E-84B8-6EC868BA8510

Q33917755-7C3E9277-440E-4FC6-8B62-AB821FED3925

Q33917755-8A526EFB-781D-40B0-AF7F-0B9FDCAADCBC

Q33917755-ABA70CA2-B2E5-4125-9847-53ED3EA018FE

Q33917755-F62498D9-D0F5-48F9-B558-6B89E7347D6B

Q33917755-ef941aa5-44ff-dd66-6c22-08d5bb02989f

P577

Q33917755-BC01732D-56C6-4C6E-8CB9-9714ACC9D3DB

P5875

Q33917755-4E65A70B-614D-4FAD-9945-EAA8EAEFDF9B

P698

Q33917755-756CA247-D1C7-45BC-B2D6-C7186F858E5F

P921

Q33917755-83C1C07C-8271-40CB-85FE-6727C0700AA9

P932

Q33917755-514334EB-A468-4888-9366-32EE8628F234

P356

J.PHRS.2009.12.011

P1433

Pharmacological Research

P1476

Enabling individualized therapy through nanotechnology

@en

P2093

Alessandro Grattoni

http://www.w3.org/2001/XMLSchema#string

Ali Bouamrani

http://www.w3.org/2001/XMLSchema#string

Anne Meyn

http://www.w3.org/2001/XMLSchema#string

Biana Godin

http://www.w3.org/2001/XMLSchema#string

Christine A Smid

http://www.w3.org/2001/XMLSchema#string

Jason H Sakamoto

http://www.w3.org/2001/XMLSchema#string

Matthew Landry

http://www.w3.org/2001/XMLSchema#string

Mauro Ferrari

http://www.w3.org/2001/XMLSchema#string

Rachel M Buchanan

http://www.w3.org/2001/XMLSchema#string

Rita E Serda

http://www.w3.org/2001/XMLSchema#string

P2860

Targeted nanoparticles for imaging incipient pancreatic ductal adenocarcinoma

Self-assembling nanofibers inhibit glial scar formation and promote axon elongation after spinal cord injury

Biomaterials approach to expand and direct differentiation of stem cells

Mammalian pharmacokinetics of carbon nanotubes using intrinsic near-infrared fluorescence

Openings between defective endothelial cells explain tumor vessel leakiness

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

In vivo imaging of tumors with protease-activated near-infrared fluorescent probes

Mass spectrometry-based proteomics

P304

57-89

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.PHRS.2009.12.011

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

62

http://www.w3.org/2001/XMLSchema#string

P50

Ennio Tasciotti

Anne L van de Ven

Shivakumar I Ranganathan

P577

2010-01-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40833152

http://www.w3.org/2001/XMLSchema#string

P698

20045055

http://www.w3.org/2001/XMLSchema#string

P921

P932

2886806

http://www.w3.org/2001/XMLSchema#string